NICOLE DIANE GIN: Open Payments
NPI 1497369334 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 80 payments from 28 companies in 2025. Trend: 2023 $1,549 · 2024 $1,607 · 2025 $1,636
Food & beverage: $1,636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $212 |
| GlaxoSmithKline, LLC. | 16 | $196 |
| Janssen Biotech, Inc. | 8 | $153 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Merck Sharp & Dohme LLC | 4 | $84 |
| Genmab U.S., Inc. | 3 | $84 |
| Ipsen Biopharmaceuticals, Inc | 3 | $76 |
| ABBVIE INC. | 3 | $67 |
| GENZYME CORPORATION | 3 | $61 |
| PFIZER INC. | 2 | $57 |
Products named: JEMPERLI, LYNPARZA, ENHERTU, KEYTRUDA, Tivdak, Onivyde, IBRANCE, DARZALEX.
Industry payments across AZ — which companies pay providers there.
